Rheolytic thrombectomy combined with a protective filter and platelet glycoprotein IIb/IIIa receptor inhibitors in rescue angioplasty.
نویسندگان
چکیده
Rescue angioplasty is used in patients in whom thrombolysis has been unsuccessful, in order to achieve a better restoration of flow and to improve left ventricular function and the long term prognosis. However, patients who undergo rescue angioplasty have a higher rate of reocclusion of the vessel or distal embolism, resulting in increased mortality. Rheolytic thrombectomy, which reduces the quantity of thrombus and improves flow in the vessel, has been used successfully in such cases. We describe a case in which rheolytic thrombectomy was applied during late rescue angioplasty in order to achieve immediate restoration of flow in the vessel.
منابع مشابه
Rheolytic thrombectomy and platelet glycoprotein IIb/IIIa blockade for stent thrombosis.
Conventional transcatheter-based strategies result in good procedural success but poor clinical outcome in the treatment of intracoronary stent thrombosis. A combined approach of mechanical thrombus burden reduction using AngioJet rheolytic thrombectomy with adjunctive glycoprotein (GP) IIb/IIIa antagonists has not been studied. Between July 1998 and August 2000, 15 patients (17 procedures) und...
متن کاملFasting and medical issues during Ramadan.
1. Topol EJ, Moliterno DJ, Herrmann HC, et al. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N Engl J Med. 2001;344: 1888-1894. 2. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigato...
متن کاملRheolytic therapy combined with intragraft abciximab for treatment in acute myocardial infarction.
After coronary artery bypass graft (CABG) surgery, patients can present with challenging lesions in the setting of acute coronary syndrome, particularly with high clot burden. Techniques including thrombectomy and local delivery of glycoprotein IIb/IIIa inhibitors have been utilized for these saphenous venous graft lesions. We report a case involving a post-CABG patient presenting with an acute...
متن کاملGlycoprotein IIb/IIIa inhibitors in clinical practice.
Glycoprotein IIb/IIIa (GP IIb/IIIa) inhibitors were developed in the early 1990’s with the purpose of providing maximum platelet aggregation blockade. At first they were used adjunctly with balloon coronary angioplasty to reduce acute occlusion of the vessel treated and its complications such as periprocedural acute myocardial infarction (MI). The dissection of the vessel after balloon dilation...
متن کاملEarly glycoprotein IIb–IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis
BACKGROUND Even though time-to-treatment has been shown to be a determinant of mortality in primary angioplasty, the potential benefits from early pharmacological reperfusion by glycoprotein (Gp) IIb-IIIa inhibitors are still unclear. The aim of this meta-analysis was to combine individual data from all randomised trials conducted on facilitated primary angioplasty by the use of early Gp IIb-II...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese
دوره 46 6 شماره
صفحات -
تاریخ انتشار 2005